In many United States households, there are many substances used to control the exposure of our children to mosquitoes, mice and rats. This review provides information on common mosquito repellents and rodenticides used in households and discusses their toxicity, in order to help pediatricians better advise their patients of their proper use.
Introduction
In many United States households, there are many substances used to control the exposure of our children to mosquitoes, mice and rats. This is necessary to ensure the proper sanitation of our homes and to prevent diseases transmitted by these vectors. Household pesticides are a common cause of potential toxic exposures in young children because of their ready availability. This review is designed to provide information on mosquito repellents and rodenticides, to discuss their toxicity and to help pediatricians better advise their patients on the proper use of these agents.
Mosquito repellents
It has been estimated that mosquitoes transmit disease to more than 700 million people annually worldwide [1] . With the emergence of West Nile Virus throughout North America there has been an increased awareness and utilization of insect repellents. West Nile Virus is transmitted by mosquitoes and can cause an infectious encephalitis. There are several repellents commonly available in the United States that are both synthetic and natural.
DEET DEET -N,N-diethyl-3-methylbenzamide or N,Ndiethyl-m-toluamide -is the most commonly used mosquito repellent in the United States. It was first developed by the US Department of Agriculture for use by the military in 1946. It became available for use by the general public in 1957. It has been estimated that about 30-38% of the US population uses a DEET-based insect repellent annually [2, 3] . In 2004, the American Association of Poison Control Centers data showed 10 917 exposures reported, of which 7485 cases were in children less than 6 years of age [4 • ].
DEET-based products are available in the United States in preparations containing 5-100% DEET. These are marketed as solutions, lotions, creams, gels, aerosol and pump sprays, as well as impregnated towelettes. Table 1 describes selected products available and their concentration of DEET. These products have proven to be effective against many species of mosquitoes, biting flies, chiggers, fleas and ticks. In a study in the New England Journal of Medicine in 2002, DEET-containing products were compared with other mosquito repellents to test their efficacy. The results showed that DEET-based products provided the longest lasting, complete protection against mosquitoes, and the higher the concentration, the longer the duration. They concluded that the non-DEET products currently available provide protection for significantly shorter durations than those containing DEET [5] . Several mathematical models of effectiveness show that the protection offered by mosquito repellents are proportional to their concentration. The model's curve tends to plateau at higher concentrations, suggesting that there is little additional protection at doses exceeding a concentration of 50% DEET [2] . It is felt that, under most circumstances, products containing between 10 and 30% DEET provide sufficient protection.
The dermal absorption of products containing 100% DEET is thought to be 5.63%. If the product contains ethanol, which enhances transdermal pharmaceutical absorption, the dermal absorption is enhanced to approximately 8.41%. Most of the applied dose is excreted within 12 hours predominantly in the urine. Also, accumulation of DEET within the epidermis is not felt to be significant [6] .
In 1980, more than 30 studies were carried out as part of the Environmental Protection Agency's Reregistration Standard for DEET. These studies assessed its oncogenicity and developmental, reproductive and neurologic toxicity. These studies revealed no new toxicities under normal usage circumstances. As such, no changes were necessary to commercial production and product availability [2] .
There are several case reports of DEET toxicity. Most case reports of toxicity are seen in adults with ingestion or excessive dermal application of the chemical. Reported toxic effects include irritability, weakness, ataxias, tremors, confusion, agitation, slurred speech, athetosis, hypotension, seizures and coma [7] [8] [9] . Dermal effects include pruritus, urticaria, bullous eruption, angioedema and conjunctival irritation. The case reports published do not determine causation and therefore should be interpreted carefully. Chronic toxicity studies have not found evidence of carcinogenicity. There may be more toxic effects in patients with chronic exposures, such as those with repeated application of DEET or those using combination products with sunscreen [10] .
A study analyzing 20 764 exposures involving DEET reported to poison control centers from 1993 to 1997, showed that approximately 70% of the cases reported no symptoms related to the exposure. These exposures included ingestions, inhalation, dermal, ocular and those with multiple types of exposure. The largest percentage of reported exposures involved infants and children who were found to have less severe outcomes than those of adults with similar exposure. In fact, most of these exposures reported no ill effects. Only 4% of cases experienced a moderate to severe effect [11] .
It is not recommended to use DEET-based products that also contain sunscreen. The recommendation for reapplying sunscreen is different than that of repellents and can lead to increased exposure to DEET. It has also been shown that the combination product may reduce the sunscreen's effectiveness [2] .
A study published in the American Journal of Industrial Medicine in 2005 suggested that a large number of children using DEET-based repellents had practices leading to undesirable exposure. These practices included choosing products containing more than 10% DEET, applying it more than once, not washing off the repellent before going to bed and treating the child's clothing as well as the skin [12 
DEET has a remarkable safety profile with millions of people using this product worldwide. The proper selection and application of this product can reduce its potential toxicity while providing adequate protection against mosquito-transmitted diseases in children. The recommendations of the American Academy of Pediatrics (AAP) for the use of mosquito repellents is described in Table 2 [13] .
Other mosquito repellents
Not included in the studies above are two additional products, picaridin and oil of lemon eucalyptus (p-methane 3,8-diol (PMD)), which have recently been shown to have an efficacy similar to that of DEETbased repellents. The Center for Disease Control (CDC) has recommended these products as alternatives to DEET in the prevention of West Nile Virus [14] .
Picaridin, KBR 3023, has been used in Europe and Australia as an insect repellent for many years. Currently, it is available in the United States as Cutter Advanced in a 7% picaridin solution. It is felt that it is better tolerated Oil of lemon eucalyptus, a plant-based repellent, has also been reported as an alternative to DEET. According to the label, oil of lemon eucalyptus products should not be used in children under 3 years of age. Its mechanism of action has not been determined. In one study, its complete-protection time was 120.1 minutes, with a range of 60-217 minutes [5] . In studies using laboratory animals, oil of lemon eucalyptus showed no adverse effects except for eye irritation [16] . Little evidence of its toxicity exists at this time. Long-term follow-up studies of picaridin and oil of lemon eucalyptus need to be performed to establish their safety in humans.
For more information about using mosquito repellants, consult the AAP web site (www.aap.org/famikly/wnv-jun03.htm), Environmental Protection Agency (EPA) web site (www.epa.gov) or consult the National Pesticide Information Center (NPIC), which is cooperatively sponsored by Oregon State University and the US EPA (www.npic.orst.edu or 1-800-858-7378).
Rodenticides -the superwarfarins
There is a wide variety in the types of rodenticides used within households in the United States. Warfarin and other anticoagulant rodenticides were developed initially to be highly toxic to rodents and less toxic to humans. Rodents have become resistant to warfarin baits and, therefore, long-acting anticoagulants were developed. These newer agents are more potent and induce a prolonged anticoagulant effect. This is why they are known as 'superwarfarins'. They include the 4-hydroxycoumarins, brodifacoum, bromodialone, difenacoum and the inadione derivative chlorphacinone. Brodifacoum appears to be the most common one in the United States [17] . The placement of the bait traps makes accidental ingestion by children a realistic concern. The AAPCC reported 16 054 human exposures to superwarfarins in 2004, 14 229 in children less than 6 years of age [4 • ]. The triage of children with unintentional ingestions of superwarfarin compounds to healthcare facilities, as well as the clinical approach to these patients, has changed over the last 5 years based on new evidence published.
A prospective study of 110 children who ingested superwarfarins revealed eight patients having a prothrombin time ratio of at least 1.2. None of the children showed any clinical evidence of bleeding. The duration of the prothrombin time elevation could not be determined due to lack of prothrombin time values after 48 hours. These authors recommend a prothrombin time be checked at 24 and 48 hours after superwarfarin ingestions [18] .
A retrospective review of 542 children with superwarfarin exposure from 1993 to 1994 did not show any significant coagulation abnormality on follow-up prothrombin times and/or international normalized ratio measurements. Of these 542 children, no child developed bleeding complications or needed antidotal treatment with vitamin K. This study was conducted using charts from a poison control center with annual call volume of 55 000 calls per year from a two-state area. The authors concluded that unintentional acute exposures to superwarfarins in normal preschool-aged children do not require any routine follow-up laboratory studies or any medical intervention [19] .
Ingels et al. [20] performed a prospective study of 545 patients younger than 6 years of age looking at the incidence of clinically important bleeding in children with superwarfarin rodenticide ingestions not treated with gastrointestinal decontamination or prophylactic vitamin K. In this study, two patients had an International Normalized Ratio of 1.5 or greater without symptoms and two patients had single nose-bleeds. No patient had a clinically important coagulopathy. The patients in this study included those who had taken up to a box of pellets. The authors thus concluded that children with acute unintentional superwarfarin ingestions of less than one box can be managed without gastrointestinal decontamination or prophylactic vitamin K. Table 2 AAP and EPA recommendations for the use of mosquito repellents in children [13] (1) Not recommended for children less than 2 months of age (2) Should not be applied more than once a day (3) Repellents should not be used in a combination product with sunscreen (4) Apply sparingly on exposed skin and/or clothing; do not use under clothing (5) Do not allow children to handle the product. When using on children, apply to your own hands first and then put it on the child. Do not apply to children's hands. (6) Avoid applying to areas around eyes and mouth and apply sparingly around ears. When using sprays, do not spray directly on face -spray on hands first and then apply to face. (7) Do not use over cuts, wounds or irritated skin (8) After returning indoors, wash treated skin with soap and water or bathe. Also wash treated clothing before wearing it again. (9) Avoid spraying in enclosed areas; do not use near food
In 2002, Shepherd et al. [17] studied unintentional brodifacoum exposures in children younger than 6 years of age. They reviewed 10 762 cases and showed that no deaths or major effects were reported. Over 50% of cases were managed outside of a healthcare facility. They also showed that decontamination had no effect on the outcome. In fact, adverse effects from decontamination therapy were reported in 42 children. The authors of this study recommend that it is reasonable for acute, unintentional ingestions of small quantities of brodifacoum by young children to be managed with home observation and parent education.
Based on the current available data, it appears safe to manage these patients at home with close follow-up with their pediatricians. There appears to be no benefit in prophylactic vitamin K or gastrointestinal decontamination in patients that have unintentional exposures to a relatively small amount of superwarfarins of less than one box. Patients should seek medical attention if they have ingested large quantities, had an intentional ingestion, have clinically significant bleeding or if there is suspected child abuse or neglect.
Conclusion
Mosquito repellents and the superwarfarin rodenticides are powerful chemicals that work to protect humans from significant vector-borne diseases. With education and correct usage, these chemicals can help in controlling diseases transmitted to children. Not all exposures lead to significant morbidity or mortality. With recognition of the current literature, most of these exposures can be managed safely at home or as an outpatient. This will ensure proper care of patients as well as decrease the overall healthcare costs contributed by unnecessary testing and treatment.
